Catubay, Yuri Maccius -.
HRN: 23-23-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/01/2023
07/08/2023
IV
500mg
Q6hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes